UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Details
Sales, net	$ 10,964	$ 10,902
Cost of goods sold	4,017	4,066
Gross profit	6,947	6,836
Operating expense
Selling, general and administrative	2,929	2,838
Research & development	130	135
Total operating expenses	3,059	2,973
Operating income	3,888	3,863
Other income	10	125
Income before provision for income taxes	3,898	3,988
Provision for income taxes	874	848
Net income	$ 3,024	$ 3,140
Earnings per common share (basic)	$ 0.83	$ 0.85
Earnings per common share (diluted)	$ 0.83	$ 0.84
Shares outstanding (basic)	3,644	3,707
Shares outstanding (diluted)	3,655	3,724
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ (54)	$ (2,449)
Total comprehensive income	$ 2,970	$ 691